# Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme

> **NCT04801147** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta** · enrollment: 76 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **BIOLOGICAL:** Dendritic Cells Vaccine

## Key facts

- **NCT ID:** NCT04801147
- **Lead sponsor:** Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06-26
- **Primary completion:** 2023-12
- **Final completion:** 2024-12-31
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04801147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04801147, "Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04801147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*